Clinical Trial Update: A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients [Phase 4]

View source ↗

Summary

Phase 4 study assessing oral gabapentin enacarbil in Japanese patients with restless legs syndrome completed, with results posted in July 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Restless Legs Syndrome (RLS) | Phase 4 | Status: COMPLETED | Results posted: 2019-07-10